{"company":{"id":4391609,"name":"BioCircuit","domain":"biocircuit.com","url":"https://alion.io/company/biocircuit"},"section":"news","answer":"BioCircuit: 13 headlines on record, 11 headlines in the last 90 days. Its story counts 10 milestones.","figures":[{"label":"Headlines","value":"13"},{"label":"In 90 days","value":"11"},{"label":"Milestones","value":"10"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":4},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":10}],"news":[{"date":"2026-10-28","kind":"News","title":"Axogen Stock Soars 22% as Nerve Repair Company Posts 26% Sales Jump, Raises 2026 Outlook After BioCircuit Deal","source":"International Business Times","url":"https://ibtimes.com.au/axogen-shares-jump-after-earnings-beat-raised-forecast-1877528"},{"date":"2026-10-28","kind":"News","title":"Axogen forecasts at least $290M 2026 revenue, adds $7M from BioCircuit while planning prostate market development in 2027","source":"seekingalpha.com","url":"https://seekingalpha.com/news/4659115-axogen-forecasts-at-least-290m-2026-revenue-adds-7m-from-biocircuit-while-planning-prostate"},{"date":"2026-10-02","kind":"News","title":"Axogen Completes Acquisition of BioCircuit Technologies, Expanding Peripheral Nerve Repair Portfolio AXGN Stock News","source":"Quiver Quantitative","url":"https://quiverquant.com/news/Axogen+Completes+Acquisition+of+BioCircuit+Technologies%2C+Expanding+Peripheral+Nerve+Repair+Portfolio"},{"date":"2026-10-01","kind":"Press release","title":"Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair","source":"morningstar.com","url":"https://morningstar.com/news/globe-newswire/9838295/axogen-completes-acquisition-of-biocircuit-technologies-adding-nervetape-the-first-fda-cleared-device-for-sutureless-peripheral-nerve-repair"}],"story":[{"title":"Won a grant $2.1M · CORDIS","url":"https://www.sbir.gov/awards?keywords=2R44NS097113-06A1"},{"title":"Won a grant $1.8M · CORDIS","url":"https://www.sbir.gov/awards?keywords=HR00112390147"},{"title":"Won a grant $2.1M · CORDIS","url":"https://www.sbir.gov/awards?keywords=1SB1NS137879-01A1"},{"title":"Won a grant $2.1M · CORDIS","url":"https://www.sbir.gov/awards?keywords=4U44NS114420-03"},{"title":"Board appointment Michael Masters, Director · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1777259/000177725922000001/"},{"title":"Raised a round Convertible Note $9M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1777259/000177725922000001/"},{"title":"Raised a round Convertible Note $3.2M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1777259/000177725921000003/"},{"title":"Won a grant $1.9M · CORDIS","url":"https://www.sbir.gov/awards?keywords=1U44NS114420-01A1"},{"title":"Raised a round Venture round $1.5M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1777259/000177725921000004/"},{"title":"Founded"}],"as_of":"2026-11-20","cite":"BioCircuit, News. Alion, Nov 20, 2026. https://alion.io/company/biocircuit/news","html_url":"https://alion.io/company/biocircuit/news","json_url":"https://alion.io/company/biocircuit/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-20T14:02:27Z"}}